|1.||Fujita, S: 2 articles (07/2001 - 01/2000)|
|2.||Sakai, I: 2 articles (07/2001 - 01/2000)|
|3.||Soga, S: 2 articles (07/2001 - 01/2000)|
|4.||Narumi, H: 2 articles (07/2001 - 01/2000)|
|5.||Yamauchi, H: 2 articles (07/2001 - 01/2000)|
|6.||Chen, D-Y: 1 article (01/2014)|
|7.||Shu, K-H: 1 article (01/2014)|
|8.||Lin, C-H: 1 article (01/2014)|
|9.||Lan, J-L: 1 article (01/2014)|
|10.||Wu, M-J: 1 article (01/2014)|
07/01/2001 - "We developed an IFN-alpha-resistant tumor cell variant, KT-1/A3R alpha 1000, from the KT-1/A3 cell line by culturing cells with increasing concentrations of IFN-alpha. "
08/01/2002 - "In this study, we first demonstrated that KT (1 microM) potentiated the apoptotic effects of nocodazole (ND, 1 nM) in COLO 205 cancer cells. "
|2.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/01/2003 - "[Analysis of IFN-alpha inducible genes in human chronic myelogenous leukemia cell line KT-1]."
01/15/1998 - "A new human leukemia cell line, KT-1, was established from a patient in the blastic crisis phase of chronic myelogenous leukemia (CML). "
07/01/2001 - "Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1."
01/01/2000 - "The mechanism of responsiveness of chronic myelogenous leukemia (CML) cells to interferon (IFN)-alpha was examined by using two subclones of CML cell line KT-1 which exhibited significantly different sensitivities to the antiproliferative and apoptosis-inducing effects of IFN-alpha. "
01/15/1998 - "Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha."
|4.||Chronic Kidney Failure (Chronic Renal Failure)
|2.||Interferon-alpha (Interferon Alfa)
|3.||Interferon-Stimulated Gene Factor 3